Pharmigene Common Stock

Pharmigene (7595.TWO) currently reports a common stock of $500M as of June 2026. That compares with $500M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Pharmigene's common stock history and peer comparisons.

Pharmigene's common stock was unchanged from $500M to $500M — essentially flat versus a year earlier (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pharmigene reported $500M in common stock as of June 2026. That compares with $500M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $500M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pharmigene, and consider following 7595.TWO for alerts when major investors trade the stock.